A multi-country outbreak of Salmonella enterica subspecies enterica serovar Agona (S. Agona) is under investigation in the European Union (EU), with cases retrospectively identified back to 2014.

This document provides an assessment of the cross-border public health risk related to the outbreak of Salmonella Poona infections in infants and young children linked to consumption of infant formula.

This document provides an assessment of the public health risk associated with a multi-country outbreak of Salmonella Enteritidis, which is epidemiologically and microbiologically linked to contaminated eggs from Poland, and can be characterised by at least six MLVA profiles and four clusters defined by WGS (PHE SNP analysis).

This rapid risk assessment looks at the reported increase in the number of Salmonella Stourbridge cases in Germany and other EU countries during the second half of 2016.

A multi-country outbreak of S. Enteritidis delineated through whole genome sequencing analysis is currently ongoing, with 314 confirmed cases in Austria, France, Ireland, Luxembourg and the United Kingdom.

This rapid risk assessment reports on a multinational outbreak of Salmonella Enteritidis which is currently ongoing among junior ice hockey players who attended the Riga Cup 2015 in Latvia.

This report assesses the risk associated with this multi-country outbreak of Salmonella Enteritidis PT 8 associated with two MLVA types, initially confirmed and delineated by whole genome sequencing methods.​

Following an increase in the number of reported human infections with Salmonella entrica serovar Stanley in some EU countries, the European Commission requested a risk assessment from ECDC.

​Since January 2014, several new cases of S. Stanley have been reported by four Member States, all potentially linked to a 2011–2012 S. Stanley outbreak.

A multi-country outbreak of Salmonella Enteritidis phage type (PT) 8 with multiple locus variable-number tandem repeat analysis (MLVA) profile 2-9-7-3-2 has been ongoing in the EU/EEA since at least July 2015. Since May 2016, 16 confirmed and 132 probable cases have been reported to ECDC by six EU/EEA countries.